Greenleaf Health, a consulting firm that advises drugmakers and device firms on FDA and other regulatory matters, has appointed former FDA Commissioner Andrew von Eschenbach as senior adviser. Von Eschenbach said he plans to "help people understand the full continuum from discovery through development to delivery, and how to do that in a way that's going to get the greatest benefits for patients in the shortest period of time."

Related Summaries